genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 6.40
+0.12 (1.91%)
At close: Mar 6, 2026
genXone Revenue
In the year 2025, genXone had annual revenue of 2.34M PLN with 31.07% growth. genXone had revenue of 917.18K in the quarter ending December 31, 2025, with 52.70% growth.
Revenue
2.34M
Revenue Growth
+31.07%
P/S Ratio
9.03
Revenue / Employee
137.86K
Employees
17
Market Cap
21.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.34M | 555.51K | 31.07% |
| Dec 31, 2024 | 1.79M | -606.63K | -25.33% |
| Dec 31, 2023 | 2.39M | -8.19M | -77.38% |
| Dec 31, 2022 | 10.59M | -12.61M | -54.36% |
| Dec 31, 2021 | 23.20M | 2.72M | 13.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Synektik Spólka Akcyjna | 706.45M |
| Voxel | 568.83M |
| InventionMed | 2.28M |
| Pharmena | 1.58M |
| Nestmedic | 1.05M |
| Medicofarma Biotech | 281.45K |